Skip to main content

Table 2 Prevalence of HIV among cervical cancer patients at TASH, Ethiopia (n = 1057)

From: Human immune deficiency virus among cervical cancer patients at Tikur Anbessa Specialized Hospital, Ethiopia: a cross sectional study

Characteristics

HIV

Positive N (%)

Negative N (%)

Age

 < 30

9 (4.64)

83 (9.62)

30–39

52 (26.80)

167 (19.35)

40–49

54 (27.84)

208 (24.10)

50–59

46 (23.71)

199 (23.06)

 >  = 60

33 (17.01)

206 (23.87)

Marital status

Single

82 (42.27)

310 (35.92)

Married

112 (57.73)

553 (64.08)

Residence

Urban

127 (65.46)

487 (56.43)

Rural

67 (34.54)

376 (43.57)

Region

Amhara

49 (25.26)

232 (26.88)

Oromia

44 (22.68)

297 (34.41)

Tigray

7 (3.61)

23 (2.67)

SNNP

22 (11.34)

73 (8.46)

Addis Ababa

69 (35.57)

211 (24.45)

Others

3 (1.55)

27 (3.13)

Religion

Orthodox

113 (58.25)

516 (59.79)

Muslim

31 (15.98)

170 (19.70)

Protestant

49 (25.26)

163 (18.89)

Other

1 (0.52)

14 (1.62)

Occupation

Unemployed

145 (74.74)

760 (88.06)

Employed

49 (25.26)

103 (11.94)

Substance use

User

71 (36.60)

111 (12.86)

None user

123 (63.40)

752 (87.14)

Number of children

No child

10 (5.15)

30 (3.48)

One child

25 (12.89)

44 (5.10)

Two child

35 (18.04)

112 (12.98)

Three child

73 (37.63)

288 (33.37)

 > 3 child

51 (26.29)

389 (45.08)

Stage

Stage I&II

74 (38.14)

383 (44.38)

Stage III &IV

120 (61.86)

480 (55.62)

Histopathology

Squamous cell carcinoma

181 (93.30)

778 (90.15)

Adenocarcinoma

13 (6.70)

85 (9.85)

Anemia

Yes

149 (76.8)

392 (45.42)

No

45 (23.20)

471 (54.58)

Treatment initiated

Surgery and chemo

5 (2.58)

12 (1.39)

Chemo

1 (0.52)

18 (2.09)

Radiotherapy

79 (40.72)

441 (51.10)

Chemo and RT

87 (44.85)

288 (33.37)

Surgery and RT

21 (10.82)

90 (10.43)

Chemo + surgery + RT

1 (0.52)

14 (1.62)